Cucurbitacin B synergistically enhances the apoptosis-inducing effect of arsenic trioxide by inhibiting STAT3 phosphorylation in lymphoma Ramos cells

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Leukemia and Lymphoma

• Publication date

  2017-02-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/10428194.2017.1289521PMID 28278714
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of HER2-integrin signaling by Cucurbitacin B leads to in vitro and in vivo breast tumor growth suppression

  2014cited by this paper
• Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.

  2014cited by this paper
• Acquired mutations in BCL2 family proteins conferring resistance to the BH3 mimetic ABT-199 in lymphoma.

  2014cited by this paper
• Cucurbitacin B Induced ATM-Mediated DNA Damage Causes G2/M Cell Cycle Arrest in a ROS-Dependent Manner

  2014cited by this paper
• Differential sensitivity of p44/p42-MAPK- and PI3K/Akt-targeted neuroblastoma subtypes to arsenic trioxide.

  2013cited by this paper
• Trichosanthes kirilowii Ethanol Extract and Cucurbitacin D Inhibit Cell Growth and Induce Apoptosis through Inhibition of STAT3 Activity in Breast Cancer Cells

  2013cited by this paper
• Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: a mini review

  2013cited by this paper
• Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP.

  2013cited by this paper
• Non-Hodgkin’s B-cell lymphoma: Advances in molecular strategies targeting drug resistance

  2013cited by this paper
• Functional inhibition of BCL2 is needed to increase the susceptibility to apoptosis to SMO inhibitors in diffuse large B-cell lymphoma of germinal center subtype

  2013cited by this paper
• Chemical constituents from the fruits of Trichosanthes kirilowii

  2012cited by this paper
• Biological activities and potential molecular targets of cucurbitacins: a focus on cancer

  2012cited by this paper
• Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways

  2012cited by this paper
• Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: Reduction of Wnt‐associated proteins and reduced translocation of galectin‐3‐mediated β‐catenin to the nucleus

  2012cited by this paper
• Inhibition of Stat3 expression induces apoptosis and suppresses proliferation in human leukemia HL-60 cells

  2011cited by this paper
• Cucurbitacin B suppresses the transactivation activity of RelA/p65

  2011cited by this paper
• From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia.

  2011cited by this paper
• Synergistic Apoptosis-Inducing Antileukemic Effects of Arsenic Trioxide and Mucuna macrocarpa Stem Extract in Human Leukemic Cells via a Reactive Oxygen Species-Dependent Mechanism

  2011cited by this paper
• CCL11-CCR3 interactions promote survival of anaplastic large cell lymphoma cells via ERK1/2 activation.

  2011cited by this paper
• Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment

  2010cited by this paper
• Cucurbitacin B inhibits STAT3 and the Raf/MEK/ERK pathway in leukemia cell line K562.

  2010cited by this paper
• Drug combination studies and their synergy quantification using the Chou-Talalay method.

  2010cited by this paper
• Tumour cell survival signalling by the ERK1/2 pathway

  2009cited by this paper
• Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.

  2009cited by this paper
• Cucurbitacin B induces differentiation, cell cycle arrest, and actin cytoskeletal alterations in myeloid leukemia cells.

  2008cited by this paper
• Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo

  2008cited by this paper
• Bcl-2-family proteins and hematologic malignancies: history and future prospects.

  2008cited by this paper
• Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer.

  2008cited by this paper
• Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells.

  2007cited by this paper
• Phospho‐Stat3 expression and correlation with VEGF, p53, and Bcl‐2 in gastric carcinoma using tissue microarray

  2006cited by this paper
• Arsenic trioxide in hematological malignancies: the new discovery of an ancient drug.

  2006cited by this paper
• JSI‐124 (cucurbitacin I) inhibits Janus kinase‐3/signal transducer and activator of transcription‐3 signalling, downregulates nucleophosmin‐anaplastic lymphoma kinase (ALK), and induces apoptosis in ALK‐positive anaplastic large cell lymphoma cells

  2006cited by this paper
• Arsenic trioxide: An anti cancer missile with multiple warheads

  2005cited by this paper
• Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells.

  2005cited by this paper
• STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells.

  2005cited by this paper
• Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies.

  2005cited by this paper
• Cucurbitacins and cucurbitane glycosides: structures and biological activities.

  2005cited by this paper
• Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study

  2004cited by this paper
• Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma.

  2003cited by this paper
• Cucurbitacins from Trichosanthes kirilowii as the inhibitory components on tyrosinase activity and melanin synthesis of B16/F10 melanoma cells.

  2002cited by this paper
• Ecbalium elaterium (Squirting Cucumber)—Remedy or Poison?

  2000cited by this paper
• Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells

  1999cited by this paper
• Effect of trichosanthin an anti-leukemia protein on normal mouse spleen cells.

  1998cited by this paper
• Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies.

  1997cited by this paper
• Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line.

  1993cited by this paper
• Coevolutionary adaptations of rootworm beetles (Coleoptera: Chrysomelidae) to cucurbitacins

  1986cited by this paper

• Cucurbitacin B in cancer: A comprehensive review of its targets and molecular mechanisms.

  2025cites this paper
• Recent Advances in the Application of Cucurbitacins as Anticancer Agents

  2023cites this paper
• Development and Validation of a New Analytical HPLC-PDA Method for Simultaneous Determination of Cucurbitacins B and D from the Roots of Trichosanthes kirilowii

  2022cites this paper
• The Ethanolic Extract of Trichosanthes Kirilowii Root Exerts anti-Cancer Effects in Human Non-Small Cell Lung Cancer Cells Resistant to EGFR TKI

  2022cites this paper
• Cucumber-Derived Nanovesicles Containing Cucurbitacin B for Non-Small Cell Lung Cancer Therapy

  2022cites this paper
• Diet-derived small molecules (nutraceuticals) inhibit cellular proliferation by interfering with key oncogenic pathways: an overview of experimental evidence in cancer chemoprevention

  2022cites this paper
• Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients

  2021cites this paper
• Cucurbitacins: Bioactivities and synergistic effect with small-molecule drugs

  2020cites this paper
• Therapeutic Role of Arsenic Trioxide in Cancer Protection

  2020cites this paper
• Cucurbitacin Mediated Regulation of Deregulated Oncogenic Signaling Cascades and Non-coding RNAs in Different Cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways.

  2020cites this paper
• Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model

  2020cites this paper
• In Vitro and In Vivo Antitumor Activity of Cucurbitacin C, a Novel Natural Product From Cucumber

  2019cites this paper
• Hierarchical extraction and simultaneous determination of flavones and triterpenes in different parts of Trichosanthes kirilowii Maxim. by ultra‐high‐performance liquid chromatography coupled with tandem mass spectrometry

  2019cites this paper
• Plant-Derived Immunomodulators

  2019cites this paper
• Novel activators and small-molecule inhibitors of STAT3 in cancer.

  2019cites this paper
• Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy

  2018cites this paper
• Arsenic-Based Anticancer-Combined Therapy: Novel Mechanism Inducing Apoptosis of Cancer Cells

  2018cites this paper
• The role of cucurbitacins in combating cancers: A mechanistic review

  2018cites this paper
• Cucurbitacin B Inhibits the Hippo-YAP Signaling Pathway and Exerts Anticancer Activity in Colorectal Cancer Cells

  2018cites this paper
• Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2.

  2018cites this paper
• Trichosanthes kirilowii lectin alleviates diabetic nephropathy by inhibiting the LOX1/NF-κB/caspase-9 signaling pathway

  2018cites this paper
• Trichosanthis Fructus: botany, traditional uses, phytochemistry and pharmacology.

  2018cites this paper
• Inhibition of STAT3/VEGF/CDK2 axis signaling is critically involved in the antiangiogenic and apoptotic effects of arsenic herbal mixture PROS in non-small lung cancer cells

  2017cites this paper